- Overview:
- This study is testing an investigational study drug in people recently diagnosed with type 1 diabetes.
- Staus:
- Enrolling
- Clinical Description:
- Study participants will continue their insulin therapy and will have their glucose monitored throughout the study in accordance with the study protocol. Our hope is to see if the investigational study drug can help people with T1D better control their glucose levels. Must have recently been diagnosed with type 1 diabetes and have been taking insulin therapy for 90 days or less.
- Target Age/Sex:
- 18 to 35 years old, Male & Female
- Benefits:
- Participants will receive at no cost: study product or placebo, a continuous glucose monitor, and electronic diary, a blood glucose meter, study visits and study-specific procedures.
- Study Length:
- 2.5 Years
